Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Astra Zeneca | Stoccolma | Salute | Prodotti farmaceutici | 2,47 Bln SEK | 36,3x | 8,79 | 1.594,50 SEK | -0,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 0,9% Rialzo | Fai l’upgrade a Pro+ | |
Swedish Orphan Biovitrum | Stoccolma | Salute | Prodotti farmaceutici | 119,38 Mrd SEK | 34x | -1,33 | 346,40 SEK | 2,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -4,2% Ribasso | Fai l’upgrade a Pro+ | |
Sectra | Stoccolma | Salute | Attrezzature e forniture medicali | 54,72 Mrd SEK | 122,5x | 7,46 | 284,80 SEK | 0,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -15,6% Ribasso | Fai l’upgrade a Pro+ | |
Getinge | Stoccolma | Salute | Attrezzature e forniture medicali | 54,19 Mrd SEK | 32x | -1,29 | 198,50 SEK | -1,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 13,5% Rialzo | Fai l’upgrade a Pro+ | |
Camurus AB | Stoccolma | Salute | Prodotti farmaceutici | 35,87 Mrd SEK | 154,4x | -3,72 | 612,50 SEK | 3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 26,7% Rialzo | Fai l’upgrade a Pro+ | |
Vitrolife | Stoccolma | Salute | Attrezzature e forniture medicali | 31,90 Mrd SEK | -8,4x | 0,01 | 235,20 SEK | -2,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 17,4% Rialzo | Fai l’upgrade a Pro+ | |
Medicover | Stoccolma | Salute | Fornitori e servizi sanitari | 27,78 Mrd SEK | 105x | 0,33 | 184,60 SEK | -0,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 16,6% Rialzo | Fai l’upgrade a Pro+ | |
Elekta | Stoccolma | Salute | Attrezzature e forniture medicali | 26,59 Mrd SEK | 23,4x | 18,27 | 68,75 SEK | -0,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 5,3% Rialzo | Fai l’upgrade a Pro+ | |
Vimian Group AB | Stoccolma | Salute | Prodotti farmaceutici | 23,86 Mrd SEK | -402,5x | 1,22 | 45,30 SEK | -0,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 9,7% Rialzo | Fai l’upgrade a Pro+ | |
Bonesupport | Stoccolma | Salute | Prodotti farmaceutici | 22,41 Mrd SEK | 76,7x | 0,07 | 340 SEK | -0,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -1,3% Ribasso | Fai l’upgrade a Pro+ | |
AddLife | Stoccolma | Salute | Ricerca medica e biotecnologica | 16,52 Mrd SEK | 141,1x | -2,39 | 135,10 SEK | -1,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 20,7% Rialzo | Fai l’upgrade a Pro+ | |
Xvivo Perfusion AB | Stoccolma | Salute | Attrezzature e forniture medicali | 15,06 Mrd SEK | 72,9x | 0,4 | 478,50 SEK | 0,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 17,2% Rialzo | Fai l’upgrade a Pro+ | |
BioArctic | Stoccolma | Salute | Ricerca medica e biotecnologica | 13,87 Mrd SEK | -157,2x | 1,2 | 157,80 SEK | 2,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Biotage | Stoccolma | Salute | Attrezzature e forniture medicali | 12,91 Mrd SEK | 50,1x | -26,81 | 160,80 SEK | 0,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 21,5% Rialzo | Fai l’upgrade a Pro+ | |
Implantica AG | Stoccolma | Salute | Attrezzature e forniture medicali | 12,09 Mrd SEK | -53,2x | 2,28 | 42,45 SEK | -0,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 32% Rialzo | Fai l’upgrade a Pro+ | |
Biogaia | Stoccolma | Salute | Prodotti farmaceutici | 10,25 Mrd SEK | 30,4x | -7,71 | 101,30 SEK | 2,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Arjo | Stoccolma | Salute | Attrezzature e forniture medicali | 9,81 Mrd SEK | 19,4x | 0,65 | 35,88 SEK | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 11,5% Rialzo | Fai l’upgrade a Pro+ | |
Ambea | Stoccolma | Salute | Fornitori e servizi sanitari | 7,90 Mrd SEK | 15,1x | 0,2 | 92,95 SEK | 0,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 19,2% Rialzo | Fai l’upgrade a Pro+ | |
Attendo International publ AB | Stoccolma | Salute | Fornitori e servizi sanitari | 7,64 Mrd SEK | 19,6x | 0,1 | 49,50 SEK | 1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 26,5% Rialzo | Fai l’upgrade a Pro+ | |
Swedencare | Stoccolma | Salute | Prodotti farmaceutici | 7,33 Mrd SEK | 119x | 1,97 | 46,36 SEK | 1,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 23,8% Rialzo | Fai l’upgrade a Pro+ | |
Surgical Science Sweden | Stoccolma | Salute | Attrezzature e forniture medicali | 6,42 Mrd SEK | 32,4x | -2,14 | 125,50 SEK | -0,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Cellavision | Stoccolma | Salute | Attrezzature e forniture medicali | 6,19 Mrd SEK | 42,9x | 0,92 | 260,50 SEK | -6,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -7,1% Ribasso | Fai l’upgrade a Pro+ | |
Raysearch Laboratories | Stoccolma | Salute | Attrezzature e forniture medicali | 5,41 Mrd SEK | 35,7x | 0,2 | 157,80 SEK | 0,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 27,2% Rialzo | Fai l’upgrade a Pro+ | |
Flerie AB | Stoccolma | Salute | Prodotti farmaceutici | 3,51 Mrd SEK | -423,8x | 44,62 SEK | -0,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | |||
Probi | Stoccolma | Salute | Prodotti farmaceutici | 3,04 Mrd SEK | 279,6x | -7,39 | 267 SEK | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Medistim ASA | Stoccolma | Salute | Attrezzature e forniture medicali | 3,01 Mrd SEK | 29,9x | -3 | 170,49 SEK | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Bioinvent | Stoccolma | Salute | Ricerca medica e biotecnologica | 2,92 Mrd SEK | -7,6x | 0,31 | 43,75 SEK | 0,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
BICO Group | Stoccolma | Salute | Attrezzature e forniture medicali | 2,82 Mrd SEK | -1,8x | 0,25 | 40 SEK | 0,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Hansa Biopharma | Stoccolma | Salute | Ricerca medica e biotecnologica | 2,61 Mrd SEK | -3,5x | -0,12 | 38,74 SEK | -2,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
ADDvise Group AB A | Stoccolma | Salute | Attrezzature e forniture medicali | 2,48 Mrd SEK | 7,3x | 0,29 | 12,45 SEK | 7,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 25% Rialzo | Fai l’upgrade a Pro+ |